Lockheed and Boeing's rivalry shapes air forces worldwide. This deep dive analyzes key programs and market dynamics to declare a winner.
National Security Journal on MSN
Canada Is Stalling for Time on F-35 Stealth Fighter
Prime Minister Mark Carney’s promised September decision on Canada’s F-35 program has slipped, with Defence Minister David McGuinty confirming the review continues. -Beyond costs and timelines, Ottawa ...
The GE F-414 jet engine deal between India and the US is facing challenges. India is considering Safran SA of France as an ...
National Security Journal on MSN
Coming Soon: The Great FCAS 6th-Generation Fighter Divorce?
Politico’s report on Germany weighing alternatives to the Franco-German-Spanish FCAS raises a hard question: what if Paris and Berlin split before Phase 2? -FCAS’s core fight is workshare and control ...
The Aviationist on MSN
Raytheon Tests Ground-Launched Variant of GBU-53 StormBreaker
The new variant was designed, developed and tested in 50 days, with the test in the Mojave Desert using a COTS rocket motor. Raytheon has announced the ...
FLYING Magazine on MSN
Alaska’s Ryan Air Bets on Beta Electric Aircraft
A cargo carrier specializing in moving freight across the remote Alaska Bush is the latest customer for Vermont-based Beta ...
The Aviationist on MSN
Helsing Unveils CA-1 Europa Autonomous UCAV
The CA-1 Europa aims to deliver affordable mass and strategic autonomy through AI-powered air combat and multi-role mission flexibility. German defense ...
Soto has more than 40 years of experience in the aviation industry, which includes negotiating comprehensive product support ...
Peru will probably decide in October which fighter jet it will choose to replace its aging fleet, the commander of the country's air force said on Sunday in an interview.
Modern EVs promise efficiency, but the original Mini proved you can have small, smart, and fun - without all the apps or the ...
AMT-130 was generally well-tolerated, with a manageable safety profile at both doses. As of June 30, 2025, no new drug-related serious adverse events have been observed since December 2022. The most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results